CEBPA and acute myeloid leukemia: However, Cy3-MTL-CEBPA treatment did result in a significant 2-fold increase in Cy3 fluorescence in human AML cells in the spleen (p = 0.004), indicating effective delivery of Cy3-RNA to a proportion of spleen-localized leukemic cells (Figures 2A and 2B).